Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(24h)(Taizhou Overseas Pharma)

维格列汀二甲双胍缓释片（24h）（越洋医药）

Report date: 2025/08/29 15:32:43

Base Information

Drug NameVildagliptin and Metformin Hydrochloride Extended-Release Tablets(24h)(Taizhou Overseas Pharma)
Drug Alias NameMetformin/Vildagliptin维格列汀•盐酸二甲双胍Metformin Hydrochloride/Vildagliptin维格列汀和盐酸二甲双胍Vildagliptin and Metformin +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG